SCHEMBL25112924

SCHEMBL25112924

c1cnc2c(c1)ccc1ccc(-c3ccc(-c4ccc(-c5cc6ccc7cccc8c9ccccc9c9ccccc9c(c5)c6c78)cc4)c4ccccc34)nc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 5/20 0.37
▸ CCR8 P51685 5/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ CCR5 P51681 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ GMNN O75496 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ THPO P40225 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112967 0.92 CCR1 (0.38) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL25112880 0.92 CCR1 (0.40) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL25112905 0.88 CCR1 (0.43) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL18904490 0.85 CCR1 (0.41) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL18904450 0.85 CCR1 (0.41) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL25766687 0.85 CCR1 (0.43) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL25766674 0.85 CCR1 (0.43) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL25112932 0.85 CCR1 (0.40) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL18904492 0.84 CCR1 (0.40) CCR1CCR8KDM4ECCR5CYP1A2
SCHEMBL25112793 0.84 CYP1A2 (0.40) CCR1CCR8KDM4ECCR5CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 CCR1 1810/4885CCR8 3519/4885KDM4E 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback